Susan Mary Galbraith
Corporate Officer/Principal bei ASTRAZENECA PLC
Profil
Susan Mary Galbraith is currently the Executive VP-Oncology Research & Development at AstraZeneca PLC.
She previously worked as an Independent Non-Executive Director at Horizon Discovery Group Ltd.
from 2014 to 2020.
She also served as a Director at the American Association for Cancer Research.
In addition, she was a Member-Supervisory Board at BB Biotech AG from 2020 to 2021.
Prior to that, she held the position of Vice President-Oncology & Clinical Biomarkers at Bristol-Myers Squibb Pharmaceuticals Ltd.
from 2008 to 2010.
Dr. Galbraith obtained her undergraduate degree from The University of Manchester, her graduate degree from the University of Cambridge, and her doctorate from the University of London.
Aktive Positionen von Susan Mary Galbraith
| Unternehmen | Position | Beginn |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2010 |
Ehemalige bekannte Positionen von Susan Mary Galbraith
| Unternehmen | Position | Ende |
|---|---|---|
| BB BIOTECH AG | Direktor/Vorstandsmitglied | 02.07.2021 |
| HORIZON DISCOVERY GROUP PLC | Direktor/Vorstandsmitglied | 30.04.2020 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | 01.01.2010 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Susan Mary Galbraith
| University of London | Doctorate Degree |
| The University of Manchester | Undergraduate Degree |
| University of Cambridge | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| BB BIOTECH AG | Finance |
| Private Unternehmen | 3 |
|---|---|
Horizon Discovery Group Ltd.
 Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
